Manoj Manickam

3.9k citations

59 papers · 3.0k indexed · 2 hit papers · h-index 20

Cell Biology top 1%
Nutrition and Dietetics top 1%
Molecular Biology
Infectious Diseases top 5%
Computational Theory and Mathematics top 1%

Co-authors: Thanigaimalai Pillaiyar Vigneshwaran Namasivayam Sang‐Hun Jung Sangeetha Meenakshisundaram Yoshio Hayashi M. Alagar P. Prabunathan Hariharan Arumugam
Topics: Synthesis and biological activity (9 papers)Bioactive Compounds and Antitumor Agents (7 papers)Synthesis of heterocyclic compounds (7 papers)
Cited by: Biochemistry Cell Biology Dermatology
Journals: Journal of Medicinal Chemistry Industrial & Engineering Chemistry Research Drug Discovery Today
Partner nations: India South Korea Germany

In The Last Decade

Manoj Manickam

57 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors

2017 710 citations Thanigaimalai Pillaiyar, Manoj Manickam et al. Journal of Enzyme Inhibition and Medicinal Chemistry profile →
An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy

2016 562 citations Thanigaimalai Pillaiyar, Manoj Manickam et al. profile →

Peers

Countries citing papers authored by Manoj Manickam

Since Specialization

Citations

This map shows the geographic impact of Manoj Manickam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manoj Manickam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manoj Manickam more than expected).

Fields of papers citing papers by Manoj Manickam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manoj Manickam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manoj Manickam. The network helps show where Manoj Manickam may publish in the future.

Co-authorship network of co-authors of Manoj Manickam

This figure shows the co-authorship network connecting the top 25 collaborators of Manoj Manickam. A scholar is included among the top collaborators of Manoj Manickam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manoj Manickam. Manoj Manickam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Vitro and In Vivo Anti-Inflammatory Evaluation of the Whole Plant Extracts of Crotalaria Biflora (L) 2021 ·Pharmacognosy Journal ·(unknown),Manoj Manickam,(unknown),(unknown)	3
2	Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19 2021 ·Archiv der Pharmazie ·Manoj Manickam,Sangeetha Meenakshisundaram,Thanigaimalai Pillaiyar	13
3	Chloroquine Analogs: An Overview of Natural and Synthetic Quinolines as Broad Spectrum Antiviral Agents 2020 ·Current Pharmaceutical Design ·Pallaval Veera Bramhachari,(unknown),Sangeetha Meenakshisundaram,(unknown),Alavala Matta Reddy,Thanigaimalai Pillaiyar,Manoj Manickam,(unknown)	8
4	A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery 2020 ·European Journal of Medicinal Chemistry ·Thanigaimalai Pillaiyar,Sangeetha Meenakshisundaram,Manoj Manickam,Sankaranarayanan Murugesan	88
5	Design, synthesis and anticancer activity of 2-amidomethoxy-1,4-naphthoquinones and its conjugates with Biotin/polyamine 2020 ·Bioorganic & Medicinal Chemistry Letters ·Manoj Manickam,(unknown),Thanigaimalai Pillaiyar,(unknown),(unknown),Seung Jin Lee,Jong Seong Kang,Sang‐Hun Jung	10
6	Identification of diphenylalkylisoxazol-5-amine scaffold as novel activator of cardiac myosin 2020 ·Bioorganic & Medicinal Chemistry ·(unknown),Venkateswararao Eeda,Manoj Manickam,(unknown),Jong Seong Kang,Sang‐Hun Jung	3
7	Design and synthesis of sulfonamidophenylethylamides as novel cardiac myosin activator 2019 ·Bioorganic & Medicinal Chemistry ·Manoj Manickam,Thanigaimalai Pillaiyar,Vigneshwaran Namasivayam,(unknown),Niti Sharma,Hitesh B. Jalani,Venkateswararao Eeda,(unknown),Eun‐Seok Jeon,(unknown),Sun‐Hee Woo,Sang‐Hun Jung	1
8	Investigation of chemical reactivity of 2-alkoxy-1,4-naphthoquinones and their anticancer activity 2018 ·Bioorganic & Medicinal Chemistry Letters ·Manoj Manickam,(unknown),(unknown),(unknown),Seung Jin Lee,Sang‐Hun Jung	23
9	Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitorsbreakdown → 2017 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Thanigaimalai Pillaiyar,Manoj Manickam,Vigneshwaran Namasivayam	710
10	Exploration of flexible phenylpropylurea scaffold as novel cardiac myosin activators for the treatment of systolic heart failure 2017 ·European Journal of Medicinal Chemistry ·Manoj Manickam,Hitesh B. Jalani,Thanigaimalai Pillaiyar,Niti Sharma,(unknown),Venkateswararao Eeda,You-Jung Lee,Eun‐Seok Jeon,Sang‐Hun Jung	11
11	Discovery of novel 3-(hydroxyalkoxy)-2-alkylchromen-4-one analogs as interleukin-5 inhibitors 2017 ·European Journal of Medicinal Chemistry ·(unknown),Venkateswararao Eeda,Manoj Manickam,Youngsoo Kim,Sang‐Hun Jung	6
12	Recent development of signaling pathways inhibitors of melanogenesis 2017 ·Cellular Signalling ·Thanigaimalai Pillaiyar,Manoj Manickam,Sang‐Hun Jung	186
13	Exploration of SAR for novel 2-benzylbenzimidazole analogs as inhibitor of transcription factor NF-κB 2017 ·Archives of Pharmacal Research ·(unknown),Venkateswararao Eeda,Manoj Manickam,Young Soo Kim,Sang‐Hun Jung	11
14	Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry 2016 ·Current Medicinal Chemistry ·Thanigaimalai Pillaiyar,Vigneshwaran Namasivayam,Manoj Manickam	8
15	Downregulation of melanogenesis: drug discovery and therapeutic options 2016 ·Drug Discovery Today ·Thanigaimalai Pillaiyar,Manoj Manickam,Sang‐Hun Jung	135
16	Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase 2016 ·European Journal of Medicinal Chemistry ·Manoj Manickam,Thanigaimalai Pillaiyar,(unknown),Venkateswararao Eeda,Hitesh B. Jalani,Nam Doo Kim,Seul Ki Lee,(unknown),Sang Kyum Kim,Sang‐Hun Jung	13
17	Exploration of benzamidochromenone derivatives with conformational restrictor as interleukin-5 inhibitors 2015 ·Bioorganic & Medicinal Chemistry ·Venkateswararao Eeda,Manoj Manickam,(unknown),Young‐Soo Kim,Sang‐Hun Jung	5
18	Inhibitors of melanogenesis: a patent review (2009 – 2014) 2015 ·Expert Opinion on Therapeutic Patents ·Thanigaimalai Pillaiyar,Manoj Manickam,Sang‐Hun Jung	65
19	Synthesis and SAR studies of bis-chromenone derivatives for anti-proliferative activity against human cancer cells 2014 ·Bioorganic & Medicinal Chemistry Letters ·Venkateswararao Eeda,Vinay K. Sharma,Manoj Manickam,Jieun Yun,Sang‐Hun Jung	37
20	In vivo anti-diabetic, antioxidant and molecular docking studies of 1, 2, 8-trihydroxy-6-methoxy xanthone and 1, 2-dihydroxy-6-methoxyxanthone-8-O-β-d-xylopyranosyl isolated from Swertia corymbosa 2014 ·Phytomedicine ·Ganesan Mahendran,Manoj Manickam,(unknown),(unknown),Shanmughavel Piramanayagam,Karnam Jayarampillai Rajendra Prasad,V. Narmatha Bai	51

About Manoj Manickam

Manoj Manickam is a scholar working on Toxicology, Organic Chemistry and Biochemistry, having authored 59 papers that have together received 3.0k indexed citations. Recurring topics across this work include Synthesis and biological activity (9 papers), Bioactive Compounds and Antitumor Agents (7 papers) and Synthesis of heterocyclic compounds (7 papers). The work is most often cited by research in Biochemistry (403 citations), Cell Biology (1.0k citations) and Dermatology (444 citations). Manoj Manickam has collaborated with scholars based in India, South Korea and Germany. Frequent co-authors include Thanigaimalai Pillaiyar, Vigneshwaran Namasivayam, Sang‐Hun Jung, Sangeetha Meenakshisundaram, Yoshio Hayashi, M. Alagar, P. Prabunathan, Hariharan Arumugam, Karnam Jayarampillai Rajendra Prasad and Rituparna Maiti. Their work appears in journals such as Journal of Medicinal Chemistry, Industrial & Engineering Chemistry Research and Drug Discovery Today.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact